Welcome to LookChem.com Sign In|Join Free

CAS

  • or

70702-47-5

Post Buying Request

70702-47-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

70702-47-5 Usage

Description

3-(3-Pyridyl)-D-alanine, also known as (αR)-α-Amino-3-pyridinepropanoic Acid, is an organic compound that serves as a key building block in the synthesis of various biologically active molecules. It features a unique combination of a pyridine ring and an alanine moiety, which contributes to its distinctive chemical properties and potential applications in medicinal chemistry.

Uses

Used in Pharmaceutical Industry:
3-(3-Pyridyl)-D-alanine is used as a precursor in the synthesis of potent and subtype-selective ligands derived from N-methylation of a somatostatin antagonist. These ligands have potential applications in the development of drugs targeting specific somatostatin receptor subtypes, which can be useful in treating various neurological and endocrine disorders.
Used in Neuropeptide Research:
3-(3-Pyridyl)-D-alanine is used as a key component in the synthesis of morphiceptin analogs, which are neuropeptides with significant μ-opioid receptor binding activities. These analogs are valuable tools in neurobiological research, particularly in the study of opioid receptors and their role in pain perception, addiction, and other related physiological processes.
Used in Oncology Research:
In the field of oncology, 3-(3-Pyridyl)-D-alanine is utilized for the synthesis of morphiceptin analogs that exhibit binding activities in brain and mammary adenocarcinoma. These analogs can be instrumental in understanding the molecular mechanisms underlying cancer progression and in the development of targeted therapies for the treatment of brain and mammary tumors.

Check Digit Verification of cas no

The CAS Registry Mumber 70702-47-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,7,0 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 70702-47:
(7*7)+(6*0)+(5*7)+(4*0)+(3*2)+(2*4)+(1*7)=105
105 % 10 = 5
So 70702-47-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N2O2.ClH/c9-7(8(11)12)4-6-2-1-3-10-5-6;/h1-3,5,7H,4,9H2,(H,11,12);1H/t7-;/m1./s1

70702-47-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H63132)  3-(3-Pyridyl)-D-alanine, 95%   

  • 70702-47-5

  • 250mg

  • 441.0CNY

  • Detail
  • Alfa Aesar

  • (H63132)  3-(3-Pyridyl)-D-alanine, 95%   

  • 70702-47-5

  • 1g

  • 1323.0CNY

  • Detail
  • Alfa Aesar

  • (H63132)  3-(3-Pyridyl)-D-alanine, 95%   

  • 70702-47-5

  • 5g

  • 5292.0CNY

  • Detail

70702-47-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(3-Pyridyl)-D-alanine

1.2 Other means of identification

Product number -
Other names D-3-PYRIDYLALANINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:70702-47-5 SDS

70702-47-5Relevant articles and documents

SMALL MOLECULE VE-PTP INHIBITORS

-

, (2022/01/05)

The present disclosure relates to compounds capable of inhibiting vascular endothelial protein tyrosine phosphatase (VE-PTP). These compounds are also capable of activating Tie2 receptor-mediated signaling. The present disclosure also relates to pharmaceutically acceptable salts of said compounds, to pharmaceutical compositions comprising such compounds and/or pharmaceutically acceptable salts thereof, and to the use of such compounds, pharmaceutically acceptable salts thereof, and/or pharmaceutical compositions comprising the same in treating diseases and/or conditions mediated by VE-PTP signaling, such as those mediated by Angiopoietm/Tie2 signaling.

METHOD FOR SYNTHESIZING OPTICALLY ACTIVE a-AMINO ACID USING CHIRAL METAL COMPLEX COMPRISING AXIALLY CHIRAL N-(2-ACYLARYL)-2-[5,7-DIHYDRO-6H-DIBENZO[c,e]AZEPIN-6-YL] ACETAMIDE COMPOUND AND AMINO ACID

-

Paragraph 0325-0331, (2016/05/10)

Objects of the present invention are to provide an industrially applicable method for producing an optically active α-amino acid in high yield and in a highly enantioselective manner, to provide a simple production method of an optically active α,α-disubstituted α-amino acid, and to provide an intermediate useful for the above production methods of an optically active α-amino acid and an optically active α,α-disubstituted α-amino acid. The present invention provides a production method of an optically active α-amino acid or a salt thereof, the production method comprising introducing a substituent into the α carbon in the α-amino acid moiety of a metal complex represented by the following Formula (1): by an alkylation reaction, an aldol reaction, the Michael reaction, or the Mannich reaction, and releasing an optically pure α-amino acid enantiomer or a salt thereof by acid decomposition of the metal complex.

Phenylalanine ammonia lyase catalyzed synthesis of amino acids by an MIO-cofactor independent pathway

Lovelock, Sarah L.,Lloyd, Richard C.,Turner, Nicholas J.

, p. 4652 - 4656 (2014/05/20)

Phenylalanine ammonia lyases (PALs) belong to a family of 4-methylideneimidazole-5-one (MIO) cofactor dependent enzymes which are responsible for the conversion of L-phenylalanine into trans-cinnamic acid in eukaryotic and prokaryotic organisms. Under conditions of high ammonia concentration, this deamination reaction is reversible and hence there is considerable interest in the development of PALs as biocatalysts for the enantioselective synthesis of non-natural amino acids. Herein the discovery of a previously unobserved competing MIO-independent reaction pathway, which proceeds in a non-stereoselective manner and results in the generation of both L- and D-phenylalanine derivatives, is described. The mechanism of the MIO-independent pathway is explored through isotopic-labeling studies and mutagenesis of key active-site residues. The results obtained are consistent with amino acid deamination occurring by a stepwise E1cB elimination mechanism. All manner of things: A competing MIO-independent (MIO=4-methylideneimidazole-5-one) reaction pathway has been identified for phenylalanine ammonia lyases (PALs), which proceeds in a non-stereoselective manner, resulting in the generation of D-phenylalanine derivatives. The mechanism of D-amino acid formation is explored through isotopic-labeling studies and mutagenesis of key active-site residues.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 70702-47-5